Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment
British journal of surgery2020Vol. 107(13), pp. 1719–1730
Citations Over TimeTop 10% of 2020 papers
Stefan van Oostendorp, Lisanne J H Smits, Y Vroom, Robin Detering, Martijn W. Heymans, Leon M.G. Moons, Pieter J. Tanis, Eelco J. R. de Graaf, Chris Cunningham, Quentin Denost, Miranda Kusters, Jurriaan B. Tuynman
Abstract
There is a substantial risk of local recurrence in patients who receive no additional treatment after local excision, especially those with high-risk pT1 and pT2 rectal cancer. The lowest recurrence risk is provided by cTME; aCRT has outcomes comparable to those of cTME for high-risk pT1 tumours, but shows a higher risk for pT2 tumours.
Related Papers
- Dermatofibrosarcoma protuberans: a case report and review of the literature.(2016)
- → Techniques in Total Mesorectal Excision Surgery(2015)21 cited
- → Whether the transanal total mesorectal excision can achieve a real total mesorectal excision(2018)
- → 'The impact of postoperative complications on short- and long-term health-related quality of life after total mesorectal excision for rectal rancer'(2022)
- → Learning Curve of Robotic Total Mesorectal Excision versus Transanal Total Mesorectal Excision - A Single-Center Study(2023)